According to a newly published market research report by 24LifeSciences, global advanced renal cell carcinoma therapeutics market was valued at USD 3.2 billion in 2023 and is projected to reach USD 5.8 billion by 2030, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 20242030. Advanced renal cell carcinoma therapeutics encompass targeted therapies,...

The cell therapy industry is rapidly transforming modern healthcare by offering innovative treatment approaches for complex diseases, including cancer, autoimmune disorders, and genetic conditions. As cell-based therapies continue to advance from research laboratories to commercial clinical applications, the demand for sophisticated instruments that support cell processing, manufacturing,...

North America represents a major market for hydrogel-based drug delivery systems due to its advanced healthcare infrastructure, substantial investments in pharmaceutical innovation, and rising focus on precision medicine. The region's growing demand for controlled-release therapies and patient-centric treatment approaches is expected to support continued market expansion. Hydrogel-Based Drug...

The United States represents a major contributor to the smart drug delivery system market, driven by advanced healthcare infrastructure, high adoption of connected medical devices, and the growing prevalence of chronic diseases such as diabetes and cardiovascular disorders. Increasing investments in digital health technologies and strong focus on patient-centered care continue to support the...